AVIDITY ON POINT
DEAD

Serial Number

99175609

Owner

Avidity Biosciences, Inc.

Attorney

Aaron D. Hendelman

Filing Date

May 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

AVIDITY ON POINT Trademark

Serial Number: 99175609

AVIDITY ON POINT is a trademark filed by Avidity Biosciences, Inc. on May 8, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Avidity Biosciences, Inc. (41 trademarks)

10578 Science Drive, Suite 125
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

May 8, 2025

Registration Date

Not Registered

Published for Opposition

December 9, 2025

Goods & Services

Custom manufacturing of oligonucleotide-conjugate based pharmaceutical therapies, oligonucleotide-antibody conjugate based pharmaceutical therapies, and oligonucleotide-antibody fragment conjugate based pharmaceutical therapies; custom manufacturing of pharmaceuticals; contract manufacturing in the field of pharmaceuticals; providing technical information in the field of pharmaceutical manufacturing

Medical and scientific research, namely, conducting clinical trials for others; providing medical and scientific research information in the fields of pharmaceuticals, biotechnology, and clinical trials; pharmaceutical research and development; pharmaceutical products development; research and development in the field of biotechnology; providing medical and scientific research information in the fields of pharmaceuticals, therapeutics, medicines and vaccines

Therapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of and prevention of musculoskeletal, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, and muscle atrophy related diseases and disorders; pharmaceutical preparations for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, autoimmune, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, dermatological, psychiatric, genetic, and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; therapeutic pharmaceutical for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, autoimmune, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, dermatological, psychiatric, genetic, and immune system related diseases and disorders; therapeutic pharmaceuticals for the treatment and prevention of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes

Providing information relating to the diagnostic, prophylactic and therapeutic properties in the field of pharmaceuticals, therapeutics, medicines, and vaccines; online medical information services, namely, providing a website related to the diagnostic, prophylactic and therapeutic properties of medicines and vaccines; none of the foregoing related to home health care services, skilled nursing services, medical and health care counseling and long-term health care planning performed by medical social workers, or medical care centers or clinics

Filing History

ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Feb 5, 2026 MAB5
ABANDONMENT - AFTER PUBLICATION
Feb 5, 2026 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Feb 4, 2026 EXAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 3, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 11, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 24, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 5, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 5, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 5, 2025 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 13, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 13, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 13, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 6, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 24, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 24, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
May 8, 2025 MAFR
NEW APPLICATION ENTERED
May 8, 2025 NWAP